NUDT15 and Hepatic failure: Furthermore, an initial screening for TPMT and NUDT15 can predict the drug response in advance, give an appropriate initial dose, and be used for post-mortem detection of severe myelotoxicity, liver failure, and drug resistance to find the genetic causes of ADR and drug resistance (Woillard et al., 2017).